- 2 -
|
|
|
- ひとお はやしもと
- 7 years ago
- Views:
Transcription
1
2 - 2 -
3 10% 50% 60 A 50% B 8.5%54.5%58.6% (QOL: Quality of Life) C 1) 2) 1992 Agency for Health Care Policy and Research
4 a) b) c) d) e) a) b) c) d)
5 (aged) (urinary incontinence) Cochrane Library PubMed Randomized Clinical Trial (RCT) ( ) I. RCT II. RCT III. IV. V. ( ) 5 I II (2 )I, II A I, II 1 B IIIV C RCT
6 ml 1) (Delirium)2) (Infection-urinary tract)3) (Atrophic vaginitis or urethritis)4) (Pharmaceuticals)5) (Psychological)6) (Excessive urine output) 7) (Restricted mobility)8) (Stool impaction) a) - 6 -
7 b) (hypermobility) (intrinsic sphincter deficiency: ISD) 30% c) d) e) - 7 -
8 2-2. ( 1) 2) 3) 1 4) 5) a) b) c) d) a) 2) 24,,
9 b) (ADL) c) 50ml 50100ml 100ml 150ml - 9 -
10 d) 1-4/hpf 4-10/hpf (detrusor hyperactivity with impaired contractile function: DHIC) (1) 50ml 50ml 50ml
11 ( ) 50ml PSA
12 1 1 QOL (I-QOL, KHQ) (International Continence Society: ICS)
13 3-1. 1) 2) 3) ml 50ml
14 3-2. A Gorman (1995) 1 Williams(1997) () 2 Beguin (1997) ) (ADL) 2) 2 ADL 3 A) (1) (2) ( ) (3) B) (bladder training)
15 C) (1) (2) (3) (4) A) Toileting assistance (prompted voiding)3 (1) C 24 (2) B
16 Colling (1992) 85 / 12 86% 4 (3) A ) Creason (1989) 85 5 Hu (1989) Schnelle (1990) ADL B) (bladder training)
17 A ( ) 3 23 Jarvis (1981) % 8 Jarvis (1981) ( + ) 84% 56% 9 Fantl (1991) % 10 Wyman (1997) 123 QOL 11 C) A A Kegel
18 Klarskov (1986) 50 42% 12 Bo (1990) 2464 ( 46) Wells (1991) 5590 ( : ) 2 14 Gallo (1997) McDowell (1999) % 16 Bo (1999) (25 ) (25 ) (27 ) B Miller (1998)
19 B Nygaard (1996) 19 Burgio (1998) (80.7% vs 68.5% vs 39.4%) 20 B Paterson (1997) (2) A Burns (1990) Burns (1993) Berghmans (1996)
20 70 Wyman (1998) (3) A 20g 100g 15 Cammu (1998) % 25 Bo (1999) 49.5 (24-70) (4) A A
21 30% Smith (1996) 2482 (18 ) (38 ) 26 Brubaker (1997) % 27 Vahtera (1997) Bower (1998) Yamanishi (2000) Schmidt (1999)Weil (2000) 73, a) b) c) 2 d) e)
22 1 1 AHCPR 1 A 1 13mg 56mg Riva (1984) Tapp (1990) 2 30 Enzelsberger (1995) Zorzitto(1989) B Burgio (2000) 197 ( 69.3 )
23 57.5% 88.5% 33 Szonyi Zorzitto (1989) Ouslander (1995) mg 12 A Mazur (1994, 36, 1995) 1 30mg mg B Whitehead (1967) mg 60mg mg B Milani (1993) 50 15mg 1200mg 2 ( 81.6% VS 78.9%)
24 1025mg 1 13 B Castleden (1986) ) 2) 3) 2 phenylpropanolamine25-100mg/ 1 2 ) A phenylpropanolamine / / A
25 Samsioe (1985) mg 2 45 van der Linden (1993) 62 (8mg 2mg ) 2 46 Kurz (1993) 21 1mg 47 Wilson (1987) Fantl (1996) / B α Kinn (1988) 36 35% 50 20g 1 2 C
26 1) 2) 3) 1) Marshall-Marchetti-Krantz 51, Burch 52 AHCPR % 84% 53, 54 Stamey Pereyra Gittes 51, Raz % 84% (AHCPR ) Kelly % (AHCPR ) Marlex mesh, Gore-Tex
27 89% 92% % 84% (AHCPR ) % 67% (AHCPR ) % 80% (AHCPR ) 2) 3) ) C
28 2) C 3) C 4) C McMurdo (1992) 78 30%
29 F 10ml Muncie (1989) Bull (1991) ) C 6) C
30 7) C 8) C 64, 65 9) C Dowd (1996) ml 300ml
31 68 10) C 11) C 4. A)., 1993 B) 11, 2000 C) Agency for Health Care Policy and Research: Urinary Incontinence in Adults: Acute and Chronic Management Clinical Practice Guideline, Gorman R. Expert system for management of urinary incontinence in women. Proceedings - the Annual Symposium on Computer Applications in Medical Care , 1995 ( II) 2. Williams KS, Crichton NJ, Roe B: Disseminating research evidence. A controlled trial in continence care. Journal of Advanced Nursing. 25: 691-8, 1997 ( II) 3. Beguin AM, Combes T, Lutzler P, Laffond G, Belmin J: Health education improves older subjects' attitudes toward urinary incontinence and access to care: a randomized study in sheltered accommodation centers for the aged. Journal of the
32 American Geriatrics Society. 45: 391-2, 1997 ( I) 4. Colling J; Ouslander J; Hadley BJ; Eisch J; Campbell E: The effects of patterned urge-response toileting (PURT) on urinary incontinence among nursing home residents. Journal of the American Geriatrics Society 40: , 1992 ( I) 5. Creason, N.S., Grybowski, J.A., Burgener, S., Whippo, C., Yeo, S., and Richardson, B. Prompted voiding therapy for urinary incontinence in aged female nursing home residents. Journal of Advanced Nursing 14: , 1989 ( II) 6. Hu, T.W., Igou, J.F., Kaltreider, D.L., Yu, L.C., Rohner, T.J., Dennis, P.J., Craighead, W.E., Hadley, E.C., and Ory, M.G. A clinical trial of a behavioral therapy to reduce urinary incontinence in nursing homes. Outcome and implications. JAMA 261: , 1989 ( I) 7. Schnelle, J. F. Treatment of urinary incontinence in nursing home patients by prompted voiding. J-Am-Geriatr-Soc. 38: , 1990 ( I) 8. Jarvis, G.J. and Millar, D.R. The treatment of incontinence due to detrusor instability by bladder drill. Progress in Clinical & Biological Research 78: , 1981 ( II) 9. Jarvis, G.J. A controlled trial of bladder drill and drug therapy in the management of detrusor instability. British Journal of Urology 53: , 1981 ( II) 10. Fantl JA, Wyman JF, McClish DK, Harkins SW, Elswick RK, Taylor JR, Hadley EC: Efficacy of bladder training in older women with urinary incontinence. JAMA 265: , 1991( I) 11. Wyman JF, Fantl JA, McClish DK, Harkins SW, Uebersax JS, Ory MG. Quality of life following bladder training in older women with urinary incontinence. International Urogynecology Journal & Pelvic Floor Dysfunction. 8: 223-9, 1997 ( I) 12. Klarskov P; Belving D; Bischoff N; Dorph S; Gerstenberg T; Okholm B; Pedersen PH; Tikjob G; Wormslev M; Hald T. Pelvic floor exercise versus surgery for female urinary stress incontinence. Urologia Internationalis 41: , 1986 ( II) 13. Bo, K., Hagen, R. H., Kvarstein, B., Jorgensen, J., and Larsen, S. Pelvic floor muscle exercise for the treatment of female stress urinary incontinence: III. Effects of two different degrees of pelvic floor muscle exercises. Neurourology & Urodynamics 9: , 1990 ( II) 14. Wells TJ; Brink CA; Diokno AC; Wolfe R; Gillis GL. Pelvic muscle exercise for stress urinary incontinence in elderly women. Journal of the American Geriatrics
33 Society. 39: , 1991 ( I) 15. Gallo ML; Staskin DR. Cues to action: pelvic floor muscle exercise compliance in women with stress urinary incontinence. Neurourology & Urodynamics. 16: , 1997 ( II) 16. McDowell BJ; Engberg S; Sereika S; Donovan N; Jubeck ME; Weber E; Engberg R. Effectiveness of behavioral therapy to treat incontinence in homebound older adults. Journal of the American Geriatrics Society. 47: , 1999( I) 17. Bo K; Talseth T; Holme I. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ 318: , 1999 ( I) 18. Miller JM; Ashton-Miller JA; DeLancey JO. A pelvic muscle precontraction can reduce cough-related urine loss in selected women with mild SUI. Journal of the American Geriatrics Society 46: 870-4, 1998 ( II) 19. Nygaard IE; Kreder KJ; Lepic MM; Fountain KA; Rhomberg AT. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence. American Journal of Obstetrics & Gynecology 174: 120-5, 1996( II) 20. Burgio KL; Locher JL; Goode PS; Hardin JM; McDowell BJ; Dombrowski M; Candib D. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial [see comments]. JAMA 280: , 1998 ( I) 21. Paterson J; Pinnock CB; Marshall VR. Pelvic floor exercises as a treatment for post-micturition dribble. British Journal of Urology 79: 892-7, 1997 ( II) 22. Burns PA; Pranikoff K; Nochajski T; Desotelle P; Harwood MK. Treatment of stress incontinence with pelvic floor exercises and biofeedback. Journal of the American Geriatrics Society 38: 341-4, 1990 ( I) 23. Burns PA; Pranikoff K; Nochajski TH; Hadley EC; Levy KJ; Ory MG. A comparison of effectiveness of biofeedback and pelvic muscle exercise treatment of stress incontinence in older community-dwelling women. Journal of Gerontology 48: M167-74, 1993 ( I) 24. Wyman JF; Fantl JA; McClish DK; Bump RCComparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. American Journal of Obstetrics & Gynecology 179: , 1998 ( I) 25. Cammu H; Van Nylen M Pelvic floor exercises versus vaginal weight cones in
34 genuine stress incontinence. European Journal of Obstetrics, Gynecology, & Reproductive Biology 77: 89-93, 1998 ( II) 26. Smith JJ 3rd. Intravaginal stimulation randomized trial. Journal of Urology 155: , 1996( II) 27. Brubaker L; Benson JT; Bent A; Clark A; Shott STransvaginal electrical stimulation for female urinary incontinence. American Journal of Obstetrics & Gynecology 177: , 1997( I) 28. Vahtera T; Haaranen M; Viramo-Koskela AL; Ruutiainen J Pelvic floor rehabilitation is effective in patients with multiple sclerosis. Clinical Rehabilitation 11: 211-9, 1997( II) 29. Riva, D. and Casolati, E. Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment. Clinical & Experimental Obstetrics & Gynecology 11: 37-42, 1984 II 30. Tapp AJ; Cardozo LD; Versi E; Cooper. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study. British Journal of Obstetrics & Gynaecology 97: 521-6, 1990 I 31. Enzelsberger H; Kurz C; Helmer H; Mittermayer F. Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study Geburtshilfe und Frauenheilkunde 55: 240-3, 1995 II 32. Zorzitto, M. L., Holliday, P. J., Jewett, M. A., Herschorn, S., and Fernie, G. R. Oxybutynin chloride for geriatric urinary dysfunction: a double- blind placebo-controlled study. Age & Ageing 18: , 1989 II 33. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 48: 370-4, 2000 ( I) 34. Szonyi G; Collas DM; Ding YY; Malone-Lee JG. Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial. Age & Ageing 24: , 1995 II 35. Ouslander JG; Schnelle JF; Uman G; Fingold S; Nigam JG; Tuico E; Jensen BB. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial. Journal of the American Geriatrics Society 43: 610-7, 1995 II 36. Mazur D; Gocking K; Wehnert J; Schubert G; Herfurth G; Alken RG. Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage. Urologe - Ausgabe A 33: ,
35 II 37. Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study. Scandinavian Journal of Urology & Nephrology 29: , 1995 I 38. Whitehead, J. A. Urinary incontinence in the aged. Propantheline bromide as an adjunct to treatment 22: , 1967 II 39. Milani R, Scalambrino S, Milia R, Sambruni I, Riva D, Pulici L, Avaldi F, Vigano R Double-blind crossover comparison of flavoxate and oxybutynin in women affected by urinary urge syndrome INT UROGYNECOL J 4: 3-8, 1993 II 40. Castleden CM; Duffin HM; Gulati RS Double-blind study of imipramine and placebo for incontinence due to bladder instability. Age & Ageing 15: , 1986 II 41. Fossberg, E., Beisland, H. O., and Lundgren, R. A. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation. Urologia Internationalis 38: , 1983 II 42. Collste L; Lindskog M. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients. Urology 30: , 1987 II 43. Lehtonen T; Rannikko S; Lindell O; Talja M; Wuokko E; Lindskog M. The effect of phenylpropanolamine on female stress urinary incontinence. Annales Chirurgiae et Gynaecologiae 75: , 1986 II 44. Weil EH; Eerdmans PH; Dijkman GA; Tamussino K; Feyereisl J; Vierhout ME; Schmidbauer C; Egarter C; Kolle D; Plasman JE; Heidler H; Abbuhl BE; Wein W. Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. :International Urogynecology Journal & Pelvic Floor Dysfunction 9: , 1998 II 45. Samsioe G; Jansson I; Mellstrom D; Svanborg A. Maturitas Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 7: :335-42, 1985( II) 46. van der Linden MC; Gerretsen G; Brandhorst MS; Ooms EC; Kremer CM; Doesburg WH. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. European Journal of Obstetrics, Gynecology, & Reproductive Biology 51: 29-33, 1993 ( II)
36 47. Kurz C; Nagele F; Sevelda P; Enzelsberger H. Intravesical administration of estriol in sensory urge incontinence--a prospective study. Geburtshilfe und Frauenheilkunde 53: :535-8, 1993 ( II) 48. Wilson PD; Faragher B; Butler B; Bu'Lock D; Robinson EL; Brown AD: Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. British Journal of Obstetrics & Gynaecology 94: , 1987 ( II ) 49. Fantl JA, Bump RC, Robinson D, McClish DK, Wyman JF. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstetrics and Gynecology 88: , 1996 ( II ) 50. Kinn AC; Lindskog M. Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women. Urology 32: , 1988 ( II) 51. Bergman,A, Ballard CA and Koonings PP. Comparison of three different surgical procedures for genuine stress incontinence: prospective randomized study. American Journal of Obstetrics & Gynecology 160: , 1989 ( I) 52. Bergman A, Koonings PP, Ballard CA. Primary stress urinary incontinence and pelvic relaxation: Prospective randomized comparison of three differnt operations. American Journal of Obstetrics & Gynecology 161: , 1989 ( I) 53. Ross J. Two techniques of laparoscopic Burch repair for stress incontinence: a prospective, randomized study. Journal of the American Association of Gynecologic Laparoscopists 3: 351-7, 1996 ( II) 54. Persson J, Wolner-Hanssen P. Laparoscopic Burch colposuspension for stress urinary incontinence: a randomized comparison of one or two sutures on each side of the urethra. Obstet Gynecol 95: 151-5, 2000 ( I) 55. Bergman A, Elia G. Three surgical procedures for genuine stress incontinence: five-year follow-up of a prospective randomized study. American Journal of Obstetrics & Gynecology 1: 66-71, 1995 ( I) 56. Henriksson, L. and Ulmsten, U. A urodynamic evaluation of the effects of abdominal urethrocystopexy and vaginal sling urethroplasty in women with stress incontinence. American Journal of Obstetrics & Gynecology. 131: 77-82, 1978 ( II) 57. Hilton P. A clinical and urodynamic study comparing the Stamey bladder neck suspension and suburethral sling procedures in the treatment of genuine stress incontinence. British Journal of Obstetrics & Gynaecology 96: , 1989 (
37 II) 58. Choe JM, Ogan K, Battino BS. Antimicrobial mesh versus vaginal wall sling: a comparative outcomes analysis [see comments. J Urol 163: , 2000 ( II) 59. Sand PK, Winkler H, Blackhurst DW, Culligan PJ. A prospective randomized study comparing modified Burch retropubic urethropexy and suburethral sling for treatment of genuine stress incontinence with low-pressure urethra. Am J Obstet Gynecol 182: 30-4, 2000 ( II) 60. Haab F, Zimmern PE, Leach GE. Urinary stress incontinence due to intrinsic sphincteric deficiency: experience with fat and collagen periurethral injections. J-Urol 157: , 1997 ( II ) 61. Muncie HL Jr, Hoopes JM, Damron DJ, Tenney JH, Warren JW. Once-daily irrigation of long-term urethral catheters with normal saline. Lack of benefit. Archives of Internal Medicine. 149: 441-3, 1989( II ) 62. McMurdo ME; Davey PG; Elder MA; Miller RM; Old DC; Malek M. cost-effectiveness study of the management of intractable urinary incontinence by urinary catheterisation or incontinence pads.journal of Epidemiology & Community Health 46: 222-6, 1992 ( II ) 63. Bull E; Chilton CP; Gould CA; Sutton TM. Single-blind, randomised, parallel group study of the Bard Biocath catheter and a silicone elastomer coated catheter. British Journal of Urology. 68: 394-9, 1991 ( II ) 64. Bainton D; Blannin JB; Shepherd AM. Pads and pants for urinary incontinence. British Medical Journal Clinical Research Ed.285: , 1982 ( II) 65. Silberberg, F. G. A hospital study of a new absorbent bed pad for incontinent patients. Medical Journal of Australia 16: , 1977 ( II) 66. Ouslander JG, Schapira M, Schnelle JF, Uman G, Fingold S, Tuico E, Glatler NJ. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Annals of Internal Medicine 122: , 1995 ( I ) 67. Ouslander, J. G., Blaustein, J., Connor, A., and Pitt, A. Habit training and oxybutynin for incontinence in nursing home patients: a placebo-controlled trial. Journal of the American Geriatrics Society 36: 40-46, 1988 ( II ) 68. Dowd TT; Campbell JM; Jones JA. Fluid intake and urinary incontinence in older community-dwelling women. Journal of Community Health Nursing 13: ( II )
38 69. Rannikko, S., Kyllastinen, M., and Granqvist, B. Comparison of long-term indwelling catheters and bed-pads in the treatment of urinary incontinence in elderly patients. Journal of Infection 12: , 1986 ( II ) 70. Berghmans LC; Frederiks CM; de Bie RA; Weil EH; Smeets LW; van Waalwijk van Doorn ES; Janknegt RA. Efficacy of biofeedback, when included with pelvic floor muscle exercise treatment, for genuine stress incontinence. Neurourology & Urodynamics. 15: 37-52, 1996 ( II ) 71. Bower WF; Moore KH; Adams RD; Shepherd R. urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. Journal of Urology 160: , 1998 ( II ) 72. Yamanishi T, Yasuda K, Sakakibara R, Hattori T, Suda S. Randomized, double-blind study of electrical stimulation for urinary incontinence due to detrusor overactivity. Urology 53: 353-7, 2000 ( II ) 73. Schmidt RA; Jonas U; Oleson KA; Janknegt RA; Hassouna MM; Siegel SW; van Kerrebroeck PE. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. Journal of Urology 162: 352-7, 1999 ( II ) 74. Weil EH, Ruiz-Cerda JL, Eerdmans PH, Janknegt RA, Bemelmans BL, van Kerrebroeck PE. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol 37: , 2000 ( II )
39
40
41 * * * *
42
@@@ @@@ @@@ @@@ A A 1 A 2 A 3 B B 1 B 2 B 3 C C 1 C 2 C 3 D D 1 D 3 E E 1 E 2 E 3 1 1 2 3 4 5 6 7 2 3 E E 1 E 2 D D 1 D 3 C C 1 C 2 C 3 B B 1 B 2 B 3 A A 1 A 2 E 3 A 3 p p p p 5 6 A A 1 2 3 B 4 9 A 1 10
特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
1 見出し1，12ポ，日本語ゴシック，英語Arial，段落後は6ポの設定です
8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%
164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10
163 特 集 SDD & SOD SDD(Selective digestive decontamination),sod(selective oropharynx decontamination), 腸内細菌叢, 耐性菌 Ⅰ はじめに SDD Selective digestive decontamination SOD Selective oropharynx decontamination
400 46 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 LVFX 100 mg 3 / 7 150 mg 2 / 7 2 2006 2008 9 LVFX PK PD 2009 7 100 mg 1 3 500 mg 1 1 AUC/MIC
Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 399 45 2012 11 5 LVFX 500 mg 1 1 20 Chlamydia trachomatis C. trachomatismycoplasma genitalium M. genitalium LVFX 1 500 mg 1 1 7 22 22 C. trachomatis 17
2009年133巻3号3月号.indb
Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine
老年医学update2007-08
Geriatric Medicine Update 2007-08 (ISBN978-4-7583-0298-2 C3002) Editor: Journal Publication Committee, The Japan Geriatrics Society 2007. 7. 1 1st ed MEDICAL VIEW, 2007 Printed and Bound in Japan Medical
*************************************************************************************** *************************************************************************************** 8 8 30 9 00 17 00 17 15 24
E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
3) Balas. C. Michele, Happ. B. Beth, Yang. Wei et al: Outcomes associated with delirium in older patients in surgical ICUs, Chest, vol.135 (1), 18-25, 2009 4) Ban Thomas; Chronic disease and depression
精神障害者
13 ACT 156-8585 2-1-8 TEL03-3304-5701 14 10 30 ACTassertive community treatment 1 ACT ACT ACT ACT Fidelity ScaleACT ACT ACT ACT ACT Fidelity 2000, 2001; 1994 Tessler & Gamache 2000 14 1 2002 1986 1994
橡
1) Abrams P, Wein AJ eds. The overactive bladder: from basic science to clinical management. Urology 50(Suppl): 1-114. 1997 2) Abrams P. Wein AJ eds. Overactive bladder and its treatment. Urology 55(Suppl):
Epidemiology and implications of falling among the elderly
Epidemiology and implications of falling among the elderly 3) Blake AJ, Morgan K, Bendall MJ : Falls by elderly people at home : prevalence and associated factors. Age Ageing 1988 ; 17 : 365-372.
慢性膵炎
- - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider
Vol. No. Honda, et al.,
A Study of Effects of Foot Bath before Exercise on Fall Prevention Yoko Honda Yoko Aso Aki Ibe Megumi Katayama Tomoko Tamaru Key Words fall prevention, foot bath, elderly, fall prevention programs Honda,
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan
CLINICAL STUDY ON FEMALE PATIENTS WITH BLADDER IRRITABILITY -Comparison between Cystitis and Urethral Syndrome- Mikio Koroku, Takaoki Hirose, Satoshi Takahashi and Yoshiaki Kumamoto Department of Urology,
20mg #tr#5*xlj lffin&+'.':, t) r+'z)vt '+D#J Centers for Medicare & Medicaid Sewices Garden AS et al. Preliminary results ofradiation Therapy Oncology Group 97-03: a randomized phase II trial of
Kansai University of Welfare Sciences Practical research on the effectiveness of the validation for the elderly with dementia Naoko Tsumura, Tomoko Mi
Practical research on the effectiveness of the validation for the elderly with dementia Naoko Tsumura, Tomoko Mitamura and Takeshi Hashino 2 1 Abstract : The present conditions to surround the elderly
本文.indd
CQ ACC/AHA PECO PatientExposure Comparison OutcomePECO low-density lipoprotein cholesterol LDL C cholesterol cholesterol intensive OR agressive CQ target LDL C PubMed Systematic Reviews Clinical Study
orororor oror CINAHL breast cancerhormonal therapyorendocrine therapyortamoxifenorgoserelinside effectorsymptomexperien
72017 3 資料 内分泌療法を受けている乳がん患者の苦痛体験に関する文献検討 A Literature Review regarding Distress Experienced by Breast Cancer Patients Undergoing Endocrine Therapy 四方文子 1), 鈴木久美 2) Ayako Shikata 1),Kumi Suzuki 2) キーワード
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
Hisao Takayasu Department of Urology, Faculty of Medicine, University of Tokyo Masaaki Ohkoshi Department of Urology, Tokai University School of Medic
COMPARATIVE CLINICAL EFFECT OF AMIKACIN AND GENTAMICIN ON COMPLICATED URINARY TRACT INFECTIONS BY DOUBLE-BLIND METHOD Tsuneo Nishiura and Yukimichi Kawada Department of Urology, Gifu University School
胆石症
,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic
.K.C.h...C...ren
4 quality of life QOL QOL QOL 3 QOL 19 mmhg 16 mmhg 14 mmhg 1 2 7 20 30 QOL QOL QOL QOL QOL QOL QOL 4 1 1 1 2 1 2 3 1 2 4 2 2 1 2 2 2 2 1 2 3 QOL 3 2 1 1 5 1 1 2 1 Abraham Wise 1 Nd YAG 2 1 200 500 200
Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa
Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Department of Obstetrics and Gynecology, Kobe University
後ろ.indd
2010 p.1-42 2010 7 The relation between food intake of pregnant women and fetal growth -case sutudy- Vol.11 No.3 p.481-4862010 11 The 10th Hamamatsu-kyungpook Joint Medical Symposium, p.54, School of Medicine,Kyugpook
臨床神経45-1.indb
59 Case of the Issue No. 9 carpal tunnel syndrome: CTS CTS CTS CTS nerve conduction study; NCS needle electromyography; nemg NCS carpal tunnel syndrome: CTS 1 CTS 4 CTS 45 65 1 3 2 CTS CTS 1999 American
MV X 5 6 Common Terminology Criteria for Adverse Events Grade 1 Grade Gy 16 QOL QOL 5 6 7, 8 9, VOL.3 NO
乳がん患者の放射線皮膚炎に対するスキンケアの指導の実際 がん放射線療法看護認定看護師とがん放射線治療に携わる看護師との比較 Educating practice of skin care for radiodermatitis of breast cancer patients: Comparison of the nurses with certified nurse in radiation therapy
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the
<30388DE288E42E696E6464>
Doshisha Journal of Health & Sports Science, 1, 53-60, 2009 53 1 Effects of Step Exercise in Healthy Older People Tomoaki Sakai 1 The purpose of this study was to determine the effect of step exercise
PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article 1 1. 2. MeSH Browser MeSH PreMEDLINE MeSH -2-
PubMed MEDLINE NLM 1879 Index Medicus 1960 MEDLARS Medical Literature Analysis and Retrieval System 1970 MEDLINE MEDlars online 1966 70 4,000 170 PubMed MEDLINE NLM National Center for Biotechnology Information
8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
J. Smooth Muscle Res. (Jap. Section) 5: J-59--J-67, 2001 URODYNAMIC STUDY IN DIAGNOSIS OF DIABETIC DYSURIA Minoru SATO First Department of Urology, To
J. Smooth Muscle Res. (Jap. Section) 5: J-59--J-67, 2001 URODYNAMIC STUDY IN DIAGNOSIS OF DIABETIC DYSURIA Minoru SATO First Department of Urology, Toho University School of Medicine, 6-11-1 Omori-nishi,
食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
Title 神経因性膀胱にともなう排尿障害に対する塩酸ブナゾシンの臨床効果 - 二重盲検比較試験による検討 - 小柳, 知彦 ; 富樫, 正樹 ; 丸, 彰夫 ; 折笠, 精一 ; 相馬, Author(s) 崎, 淳 ; 安田, 耕作 ; 阿曽, 佳郎 ; 本問, 之夫 ; 三宅, 弘厚生 ; 熊
Title 神経因性膀胱にともなう排尿障害に対する塩酸ブナゾシンの臨床効果 - 二重盲検比較試験による検討 - 小柳, 知彦 ; 富樫, 正樹 ; 丸, 彰夫 ; 折笠, 精一 ; 相馬, Author(s) 崎, 淳 ; 安田, 耕作 ; 阿曽, 佳郎 ; 本問, 之夫 ; 三宅, 弘厚生 ; 熊澤, 淨一 ; 武井, 実根雄 Citation 泌尿器科紀要 (1990), 36(10): 1233-1252
CRA3689A
AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF
4, NCCLS. Urinalysis and Collection, Transportation, and Preservation of Urine Specimens. Approved Guideline NCCLS Document GP16-A, 2001. 5. Kouri T, et al. European Urinalysis Guideline. Scand J Clin
<30332D D8CB492982D FC95E490E690B62D8FAC8FBC96BE90E690B62E706466>
A questionnaire survey on the use of placebo in clinical practice by nurses in Japan 1 1 2 2 1 4 1964 5, 6 1998 GCP 1 School of Nursing, Faculty of Medicine, Toho University 2Faculty of Medical Technology,
untitled
CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11
Ⅱ Ⅲ Ⅳ Assertive community treatment - Issues from scientific and clinical literature with implications for practice The Impact of Supported Employment and Working on Clinical and
Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad
Key words: Female with bladder irritability, Subjective symptoms, Pyuria, Bacteriuria Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution
32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ
29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27
Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c
Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic clinic, Department of Ophthalmology, (Director: Prof
終末期の呼吸困難症状への対応*松坂最終修正
Clinical Question 2017 5 27 1 PCOC 1. 12778 ( 55%, 45% NRS. 1 54, 35%. NRS. NRS,,,,,,,, Performance status, Ekstrom, M., et al.2016 J Pain Symptom Manage 51(5):816-23. . 1 85 ADL. 3,,,,. JCS200,, 40 /,
…h…L…–…†…fi…g1
RY RO RR RW LN LM LB LC MH MG MB RD RM RG LD CW SB VR BB EB PW PY PP PG PB 0 contents WR LR MR BR DR PM SM MC CB BO 0 P P7 P P5 P9 P 0 P4 P48 P54 P60 P66 P 04 RY RO RR RW RD RM RG LN LM LB LC LD MH MG
C/NC : committed/noncommitted
C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a
特 集 conditionally essential amino acid, グルタミンジペプチド (Glutamine dipeptide), 多臓器不全 Ⅰ はじめに sepsis RE- DOXS Ⅱ 重症患
143 特 集 conditionally essential amino acid, グルタミンジペプチド (Glutamine dipeptide), 多臓器不全 Ⅰ はじめに 1980 2013 sepsis RE- 173 8605 2 11 1 Ⅱ 重症患者における生体内でのグルタミンの役割 1950 Eagle 1 1970 2 1/3 40 50 144 30 conditionally
医科的 に診 た外歯瘻 図1 症 例1:右 鼻翼 基 部の瘻 孔 図2 凝 血が付着 して いる 症 例1:初 耳 展 図3 症 例1:抜 歯 後4 50: 1 日 治癒 してい る 右上 犬歯 歯 肉 の発赤 腫 脹 が 見 ら れ る 図4 症 例2:初 図5 頬 部皮 膚の 浸潤 性 発 赤腫 脹 が 見 症 例2:蜂 窩 織 炎 の 所 見 を示 図6 症 例2:初 診 か ら10日 後 に瘻
評論・社会科学 ８５号（よこ）（Ｐ）／３．佐分
well-being well-being well-being well-being QOL well-being satisfaction appraisal 69 well-being 2025 520 http : //www.mhlw.go.jp/ 2000 2004 2005 well-being 1 Walker 1996 ; Picot 1997 2003 2004 Zarit 1980
調査報告書
8 15 1 2 3 4 1 2 VTR 3 4 19 19 19 1 2 3 4 5 6-1 - 23 1 2 VTR VTR MA MA 3 2 34 1 BPO - 2 - 2 3 4 5TBS 6 41 1 2 3 4 5 63 1 520 2 3 53 17 4 17 61 17 6 12 69 17 8 7 78 17 10 16 2005 SP 86 17 12 11-3 - 95 18
untitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
HEART'S Original A case of Brugada syndrome with a high defibrillation threshold in which defibrillation was successful by Active Can off defibrillation Keisuke Kawachi, Yukei Higashi, Yuuki Honda, Kouhei
GB 3rd edition final.ppt
Complementary and Alternative Medicine (National Center for Complementary and Alternative Medicine; NCCAM) Complementary and alternative medicine is a group of diverse medical and health care systems,
jsfm_著者紹介_160520
Sarah M. A. Caney 1 European Journal of Companion Animal Practice (2015) Autumn 25 (3) EJCAP 25(3) Special issue 2015 P4 Commissioned paper* Management of the elderly cat Sarah M. A. Caney 1-01 - EJCAP
2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1
Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.
東洋医学雑誌
Vol.67 No.3 296-301, 2016 Keizo TOKUMO Department of Obstetrics and Gynecology, Chugoku Central Hospital of the Mutual aid Association of Public School Teachers, 148-13 Ohazaueiwanari, Miyuki-cho, Fukuyama,
Microsoft Word - 「閉塞性睡眠時無呼吸症候群に対する口腔内装置に関する診療ガイドライン」
日本睡眠学会と日本睡眠歯科学会は共同で 閉塞性睡眠時無呼吸症候群に対する口腔内装置に関する診療ガイドライン を作成いたしております このガイドライン ( 案 ) について 広く皆様からのご意見をお聞きするため 平成 25 年 4 月 8 日 ( 月 ) から平成年 4 月 26 日 ( 金 ) まで意見の募集 ( パブリックコメント ) を行います ご意見は電子メールにて oa_guideline@nemuri.mobi
Vol14_No1
A A CISS TEG CISS CP A AC incidents, individual characteristic, assuring behavior, stress coping behavior medication administration task To Err Is Human,, Faculty of Medicine University of Miyazaki Hospital
606 Dementia Japan Vol. 29 No. 4 October 2015 Table 1. The day care for people with severe dementia Outline Subjects Personal distribution Medical man
Dementia Japan 29 : 605-614, 2015 605 原著 要旨 1. はじめに 1 26 4.2 80 2 3 A survey of daycare facilities for dementia people in Japan Tohmi Osaki, Kiyoshi Maeda 1 650-0017 7-5 - 2 Medical Center for Dementia,
2001 2003 2005 2006 2007 2008
2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65
Fig. 1 Chemical structure of DL-8280
Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.
37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth
Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth and Foot Breadth Akiko Yamamoto Fukuoka Women's University,
越智59.qxd
Social Skills Training; SST SST Social Skills, SST, ;, SST, SST SST, ;, ; DeRosier & Marcus,, ;, a b SST Ladd & Mize, ; Hansen, Nagle, & Meyer,,, A BC SST SST SST SST SST SST, SST Goldstein & McGinnis,
０８１１１６ヨコ／妹尾江里子 １９９号
Hardy et al. Paivio Martin et al. Cognitive Specific : CS Cognitive General : CG Motivational Specific : MSMotivational General Arousal : MG A Motivational General Mastery : MG M MS MG A MG M Hardy et
04-p45-67cs5.indd
Journal of Sport and Exercise Psychology Motivation in sport and exercise. Journal of Sport and Exercise Psychology Journal of Applied Sport Psychology Psychological Review International Journal of Behavioral
untitled
19 CSPOR CRC/2009.8.8-9 2009 8 8 ( ) - CSPOR CRC SEMINAR- twatanab@oncoloplan.com http://www.oncoloplan.com - Toru Watanabe MD - 2 Phase I: Dose Finding trial Phase II : Efficacy and Safety trial Phase
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-14-ethyl-12,
h4_1_et
1 RY RO RM RG RR RW RD LN LM LB LC LD MW MG MB CW SB VR BB EB WR LR MR BR DR PM SM MC CB BO 2 3 RY RO RR RW RD RM RG LN LM LB LC LD MW MG MB 4 CW SB VR BB EB 5 PI PY PP PG PB 6 WR LR MR BR DR 7 SM MC CB
untitled
11-19 2012 1 2 3 30 2 Key words acupuncture insulated needle cervical sympathetick trunk thermography blood flow of the nasal skin Received September 12, 2011; Accepted November 1, 2011 I 1 2 1954 3 564-0034
02古郡氏李氏_a_4.indd
55 2014 e.g2004 2005 2001 1980 101990 1 2 2002 2003 25,000 20038,000 2013 10 2013 1,787 21.623 4,302 1 HUD portal.hud. gov/.../huddoc?id=pih2013 15.pdf... 2 14 105 30,000 25,000 25,296 20,000 15,000 10,000
21-07_後藤論文.smd
2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive
報告書 H22-2A-09
061-0293 1757 TEL 0133-23-1211 2.0% 0.5% in vitro QOL Quality of Life 1 MCE-400 400 mpa s Duck Algin 350M M/G 0.8 70 80 C 20% 50 C 1.0% 5 C SV-10 5 C 10 ml E TV 20H model E 1 34 R24 1 ml 5 C 30 6 12 30
平成14年8月22日
7 14 11 26 7 18 7 7 ( ) 2 7 5 3 1. 1) 2) 3) 4) 5) 6) 2. 3. 4 4. 5. 6. 5 6 7 1. 8 2. 8 3. 12 4. 15 5. 19 6. 23 7. 26 8. 28 7 1. 2000 12 2 2000 12 6 7 2001 13 2 5 6 6 1) 2) 3) 4) 5) 6) 2. 2001 13 3 1) 8
1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%
VOL. 34 S-2 CHEMOTH8RAPY 913
VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(
08医療情報学22_1_水流final.PDF
22 (1), 702002: 59 59- The Problem of Nursing Common Language for the Information Sharing in Clinical Practice The fact-finding in regard to the correspondence between name and content of nursing action
IPSJ SIG Technical Report Vol.2011-UBI-30 No /5/ , 1 1 Evaluation on Effect of Presenting False Information for Biological Information Vi
1 1 1, 1 1 Evaluation on Effect of Presenting False Information for Biological Information Visualization Systems Kenji Nakamura, 1 Takuya Katayama, 1 Tsutomu Terada 1, 1 and Masahiko Tsukamoto 1 Recentry,
小児感染免疫第27巻第4号
364 2015 C 1 2 3 4 5 6 7 8 urinary tract infection UTI 2 1 UTI 1 3 5 2,3 4 1 UTI Escherichia coli E. coli 80 5 Enterococcus 1 UTI 83 78 53 98 5 WBCs HPF 73 81 81 83 or 93 72 ororor 99.8 70 4 Key words
Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;
untitled
2303 16 2 9 1 14 5 31 (423) 1 (4), (6) C55H84ClN17O21S3 HCl (BLM-A2) 1487.47 11 2 1 4 104 2 14 5 31 [ ] ( ) ( ) 1. 15mg 30mg( ) 5 20mL 1 5mg( ) 2. 3 15mg 30mg( ) 5mL 1mg( ) 1mL 3. 5mg 15mg( ) 4. 1 2 1
橡
TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1
EAMS 2014
2014 2 10 RCT EAMS 2014 2015. 3. 31 Evidence Reports of Anma-Massage-Shiatsu: 2 Meta-Analisys and 10 Randomized Controlled Trials of Japan 31 Mar 2015 CONTENTS 1. (prologue).. 1 2. (steps for development
fl:a-221 fr:(a_222 [-O-72 3 li-o)-80 u-o-40 u-o-74 [-O-16 III-O-i3 lr-{o-2e 1 tr-g2e.3 rrr-g3e fi-o-zs rrr{tsr8 [+1e ll1g41 )isatracurium besylate besylate li-gr2 -omitapide iegenon )harmaceuticals #it
untitled
Vol. 19 No. 1 2009 13 23 Λ1 Λ2 2 1) 10 1 Infertility 1785 1978 1980 1983 IVF-ET 2) 1 1 1 6 65% 1 80% Λ1 Λ2 701-0193 288 E-Mail: hiro210691@yahoo.co.jp 13 14 2 90% 3 93% 2 10% 40% 40% 15% 5% 3) 2 4) 5)
CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A
CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A 15 180 306 7,000 1 3 mg 103 92 89.3 60 60 100 173 28 16.2 3.52.92.3 1.7 1.7 1.7 2 64 78 80 3 ST 4 5 32 6 18 65 CQ 1 307 1 7,000 2006 ; 94 11 : 2149-2168. 2 2010
sick contact1l
Clinical Question 2017 年 5 月 15 日 分野 : 内分泌テーマ : 治療 19 14 15 18 sick contact1l 170cm/68.8kg, GCSE1V1M5, HR: 120/min, BP: 104/60mmHg, RR: 30/min, SpO 2 : 96%, BT: 38.0 WBC Hb PLT CRP Cr BUN 23400 15.0 35.5
Quality of Life of Outpatients Treated with Low Anterior Resection or Anterior Resection for Colorectal Cancer orrelation Between Dyschezia and Self-c
Quality of Life of Outpatients Treated with Low Anterior Resection or Anterior Resection for Colorectal Cancer orrelation Between Dyschezia and Self-completed QOL Questionnaire- Nami Imai *1, Yoshihiro
商学 ６３‐１・２☆／５．冨田
70 1 Donabedian1980 Parasuraman, Berry, and Zeithaml1988 71 1Donabedian Donabedian1980 2 1 1 2 2 Donabedian1980 Donabedian1980 3 1 3 Donabedian1980Donabedian1982 Donabedian1985 Donabedian1966 72 1 Donabedian1968,
CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin
CHEMOTHERAPY Fig. 2 Urinary excretion of mezlocillin Fig. 1 Blood levels of mezlocillin CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels
iii 1 1 1 1................................ 1 2.......................... 3 3.............................. 5 4................................ 7 5................................ 9 6............................
JHN Journal Club 手稲渓仁会病院
JHOSPITALIST network GUIDE-IT trial; The Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure multicentre randomised clinical trial 20171010 1 70 (EF 30%), (PCI), (HbA1c
The Most Effective Exercise for Strengthening the Supraspinatus : Evaluation by Magnetic Resonance Imaging by TAKEDA Yoshitsugu and ENDO Kenji Departm
The Most Effective Exercise for Strengthening the Supraspinatus : Evaluation by Magnetic Resonance Imaging by TAKEDA Yoshitsugu and ENDO Kenji Department of Orthopedic Surgery, The University of Tokushima
ren
51 * 1 1 IT 24 2010 NHK 2010 7.14 1960 1.08 OECD 2 5 1 2011 4 World Association of Sleep Medicine WASM 3 18 World Sleep Day 2011 11 30 no. 22730552 9 3 1 4,000 5,000 1998 4 4.4 3.3 Matsuda, 2011 Cognitive
資料_斉藤
31 3 16 7 J. -J. Rousseau and His Urologic Diseases Hiroshi Saitoh (Department of Urology, Saitama Medical School, Saitama Medical Center, Kawagoe, Saitama 350-8550, Japan) Jean -Jacques Rousseau (1712-1778)
untitled
Japan College of Social Work 01 Japan College of Social Work Profile Contents Japan College of Social Work 02 01 Case 02 Case 03 Case 04 Case 05 Case 03 Japan College of Social Work Japan College of Social
66-1 石郷岡 愛.pwd
eating disorders ED ED ED ED ED ED ED ED anorexia nervosa AN bulimia nervosa BN Eating disorder not otherwise specified EDNOS DSM 5 EDNOS BN binge eating disorder BED feeding and eating disorders ED AN
SLActive_cs4.indd
SIMPLY BETTER STRAUMANN SLActive SLActive 1 SLActive SLA SLActive SLA 2,3,4,5,6,7 SLActive 1,3,4,5,6,7,8,9 3 4 2 8 SLActive SLA SLActive SLA 1 2 3 4 5 6 7 8 1,2 SLActive 2 2 4 1 SLActive SLA SLActive 11
2 A. Ramón y Cajal projectional brain map barrel Statview I I II II I I II II
1 B version1.3 A. B. C. D. E. F. G. H. 2 A. Ramón y Cajal projectional brain map barrel Statview I I II II I I II II . B-1-b 3 B-1-c 4 _m _m _m µ µ 5 Rieke et al. (1997) Spikes-Exploring the Neural Code